nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CALR—prostate cancer	0.205	0.511	CbGaD
Melatonin—CYP1B1—prostate cancer	0.0446	0.111	CbGaD
Melatonin—MPO—prostate cancer	0.0402	0.1	CbGaD
Melatonin—ESR1—Estramustine—prostate cancer	0.0395	0.112	CbGbCtD
Melatonin—CYP1B1—Flutamide—prostate cancer	0.0352	0.1	CbGbCtD
Melatonin—CYP19A1—prostate cancer	0.0327	0.0818	CbGaD
Melatonin—ESR1—prostate cancer	0.0301	0.0753	CbGaD
Melatonin—CYP1B1—Estrone—prostate cancer	0.0255	0.0724	CbGbCtD
Melatonin—ESR1—Estrone—prostate cancer	0.0255	0.0724	CbGbCtD
Melatonin—CYP2C19—prostate cancer	0.0242	0.0604	CbGaD
Melatonin—CYP1A1—prostate cancer	0.0241	0.0602	CbGaD
Melatonin—ESR1—Ethinyl Estradiol—prostate cancer	0.0227	0.0645	CbGbCtD
Melatonin—ESR1—Conjugated Estrogens—prostate cancer	0.0167	0.0474	CbGbCtD
Melatonin—CYP1A1—Flutamide—prostate cancer	0.0154	0.0439	CbGbCtD
Melatonin—CYP1B1—Mitoxantrone—prostate cancer	0.0151	0.043	CbGbCtD
Melatonin—ESR1—Estradiol—prostate cancer	0.0146	0.0416	CbGbCtD
Melatonin—CYP1B1—Estradiol—prostate cancer	0.0146	0.0416	CbGbCtD
Melatonin—CYP1A1—Estrone—prostate cancer	0.0112	0.0318	CbGbCtD
Melatonin—SLC22A8—Conjugated Estrogens—prostate cancer	0.0092	0.0262	CbGbCtD
Melatonin—CYP2C19—Bicalutamide—prostate cancer	0.00903	0.0257	CbGbCtD
Melatonin—CYP2C19—Nilutamide—prostate cancer	0.00903	0.0257	CbGbCtD
Melatonin—CYP1B1—Docetaxel—prostate cancer	0.00873	0.0248	CbGbCtD
Melatonin—SLC22A8—Estradiol—prostate cancer	0.00808	0.023	CbGbCtD
Melatonin—CYP2C9—Bicalutamide—prostate cancer	0.0075	0.0213	CbGbCtD
Melatonin—CYP2C9—Nilutamide—prostate cancer	0.0075	0.0213	CbGbCtD
Melatonin—CYP2C19—Flutamide—prostate cancer	0.00748	0.0213	CbGbCtD
Melatonin—CYP1A2—Flutamide—prostate cancer	0.0069	0.0196	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—prostate cancer	0.00651	0.0185	CbGbCtD
Melatonin—CYP1A1—Estradiol—prostate cancer	0.00642	0.0182	CbGbCtD
Melatonin—CYP1A2—Estrone—prostate cancer	0.00499	0.0142	CbGbCtD
Melatonin—CYP2C9—Estrone—prostate cancer	0.0045	0.0128	CbGbCtD
Melatonin—CYP2C9—Capecitabine—prostate cancer	0.00341	0.00969	CbGbCtD
Melatonin—CYP1A2—Conjugated Estrogens—prostate cancer	0.00326	0.00928	CbGbCtD
Melatonin—CYP2C19—Estradiol—prostate cancer	0.00311	0.00883	CbGbCtD
Melatonin—CYP1A2—Estradiol—prostate cancer	0.00287	0.00815	CbGbCtD
Melatonin—CYP2C19—Prednisone—prostate cancer	0.00267	0.0076	CbGbCtD
Melatonin—CYP2C9—Estradiol—prostate cancer	0.00258	0.00734	CbGbCtD
Melatonin—CYP19A1—semen—prostate cancer	0.002	0.0482	CbGeAlD
Melatonin—CYP1A2—Etoposide—prostate cancer	0.00187	0.00532	CbGbCtD
Melatonin—MT3—prostate gland—prostate cancer	0.00179	0.0432	CbGeAlD
Melatonin—CALM2—semen—prostate cancer	0.00173	0.0416	CbGeAlD
Melatonin—CALM1—semen—prostate cancer	0.00172	0.0414	CbGeAlD
Melatonin—EPX—bone marrow—prostate cancer	0.00164	0.0395	CbGeAlD
Melatonin—CALR—prostate gland—prostate cancer	0.00141	0.034	CbGeAlD
Melatonin—SLC22A8—urine—prostate cancer	0.00137	0.0329	CbGeAlD
Melatonin—CALR—seminal vesicle—prostate cancer	0.0012	0.0288	CbGeAlD
Melatonin—ASMT—testis—prostate cancer	0.00116	0.028	CbGeAlD
Melatonin—CYP2C19—urine—prostate cancer	0.00115	0.0276	CbGeAlD
Melatonin—CALR—epithelium—prostate cancer	0.00104	0.025	CbGeAlD
Melatonin—CALR—renal system—prostate cancer	0.000964	0.0232	CbGeAlD
Melatonin—CALR—urethra—prostate cancer	0.000947	0.0228	CbGeAlD
Melatonin—MTNR1A—testis—prostate cancer	0.000943	0.0227	CbGeAlD
Melatonin—CYP1A2—urine—prostate cancer	0.000936	0.0225	CbGeAlD
Melatonin—CYP2C9—urine—prostate cancer	0.000889	0.0214	CbGeAlD
Melatonin—NQO2—prostate gland—prostate cancer	0.000798	0.0192	CbGeAlD
Melatonin—MT3—testis—prostate cancer	0.00079	0.019	CbGeAlD
Melatonin—IDO1—lymph node—prostate cancer	0.00077	0.0185	CbGeAlD
Melatonin—CALR—bone marrow—prostate cancer	0.000729	0.0175	CbGeAlD
Melatonin—NQO2—seminal vesicle—prostate cancer	0.000675	0.0162	CbGeAlD
Melatonin—CALR—testis—prostate cancer	0.000623	0.015	CbGeAlD
Melatonin—MT3—lymph node—prostate cancer	0.000573	0.0138	CbGeAlD
Melatonin—CALM3—prostate gland—prostate cancer	0.000552	0.0133	CbGeAlD
Melatonin—NQO2—renal system—prostate cancer	0.000544	0.0131	CbGeAlD
Melatonin—NQO2—urethra—prostate cancer	0.000534	0.0129	CbGeAlD
Melatonin—CYP19A1—prostate gland—prostate cancer	0.000502	0.0121	CbGeAlD
Melatonin—SLC22A8—prostate gland—prostate cancer	0.000491	0.0118	CbGeAlD
Melatonin—Nabumetone—MPO—prostate cancer	0.000471	0.432	CrCbGaD
Melatonin—CYP1B1—prostate gland—prostate cancer	0.000469	0.0113	CbGeAlD
Melatonin—CALM3—seminal vesicle—prostate cancer	0.000467	0.0112	CbGeAlD
Melatonin—CALR—lymph node—prostate cancer	0.000452	0.0109	CbGeAlD
Melatonin—MPO—epithelium—prostate cancer	0.000451	0.0109	CbGeAlD
Melatonin—ESR1—prostate gland—prostate cancer	0.000436	0.0105	CbGeAlD
Melatonin—CALM2—prostate gland—prostate cancer	0.000433	0.0104	CbGeAlD
Melatonin—CALM1—prostate gland—prostate cancer	0.000431	0.0104	CbGeAlD
Melatonin—MPO—renal system—prostate cancer	0.000419	0.0101	CbGeAlD
Melatonin—NQO2—bone marrow—prostate cancer	0.000411	0.0099	CbGeAlD
Melatonin—CALM3—urethra—prostate cancer	0.00037	0.0089	CbGeAlD
Melatonin—CALM2—seminal vesicle—prostate cancer	0.000367	0.00882	CbGeAlD
Melatonin—NQO2—testis—prostate cancer	0.000351	0.00846	CbGeAlD
Melatonin—SLC22A8—renal system—prostate cancer	0.000335	0.00805	CbGeAlD
Melatonin—ESR1—epithelium—prostate cancer	0.00032	0.00771	CbGeAlD
Melatonin—CYP1B1—renal system—prostate cancer	0.00032	0.0077	CbGeAlD
Melatonin—CALM2—epithelium—prostate cancer	0.000318	0.00767	CbGeAlD
Melatonin—CALM1—epithelium—prostate cancer	0.000317	0.00763	CbGeAlD
Melatonin—MPO—bone marrow—prostate cancer	0.000316	0.00762	CbGeAlD
Melatonin—ESR1—renal system—prostate cancer	0.000297	0.00715	CbGeAlD
Melatonin—CALM2—renal system—prostate cancer	0.000295	0.00711	CbGeAlD
Melatonin—CALM1—renal system—prostate cancer	0.000294	0.00708	CbGeAlD
Melatonin—CALM2—urethra—prostate cancer	0.00029	0.00699	CbGeAlD
Melatonin—CALM1—urethra—prostate cancer	0.000289	0.00695	CbGeAlD
Melatonin—CALM3—bone marrow—prostate cancer	0.000284	0.00685	CbGeAlD
Melatonin—MPO—testis—prostate cancer	0.000271	0.00651	CbGeAlD
Melatonin—NQO2—lymph node—prostate cancer	0.000255	0.00613	CbGeAlD
Melatonin—CYP1A1—epithelium—prostate cancer	0.000244	0.00587	CbGeAlD
Melatonin—CALM3—testis—prostate cancer	0.000243	0.00585	CbGeAlD
Melatonin—CYP1A2—renal system—prostate cancer	0.000229	0.00552	CbGeAlD
Melatonin—CYP1A1—renal system—prostate cancer	0.000226	0.00544	CbGeAlD
Melatonin—CALM2—bone marrow—prostate cancer	0.000223	0.00538	CbGeAlD
Melatonin—CALM1—bone marrow—prostate cancer	0.000222	0.00535	CbGeAlD
Melatonin—CYP1A1—urethra—prostate cancer	0.000222	0.00534	CbGeAlD
Melatonin—CYP19A1—testis—prostate cancer	0.000221	0.00532	CbGeAlD
Melatonin—CYP1B1—testis—prostate cancer	0.000207	0.00497	CbGeAlD
Melatonin—MPO—lymph node—prostate cancer	0.000196	0.00472	CbGeAlD
Melatonin—ESR1—testis—prostate cancer	0.000192	0.00462	CbGeAlD
Melatonin—CALM2—testis—prostate cancer	0.000191	0.0046	CbGeAlD
Melatonin—CALM1—testis—prostate cancer	0.00019	0.00457	CbGeAlD
Melatonin—Nabumetone—PTGS2—prostate cancer	0.000177	0.162	CrCbGaD
Melatonin—CALM3—lymph node—prostate cancer	0.000176	0.00424	CbGeAlD
Melatonin—Almotriptan—CYP2E1—prostate cancer	0.000169	0.155	CrCbGaD
Melatonin—Almotriptan—CYP2C19—prostate cancer	0.000167	0.153	CrCbGaD
Melatonin—CYP19A1—lymph node—prostate cancer	0.00016	0.00386	CbGeAlD
Melatonin—CYP1B1—lymph node—prostate cancer	0.00015	0.00361	CbGeAlD
Melatonin—ESR1—lymph node—prostate cancer	0.000139	0.00335	CbGeAlD
Melatonin—CALM2—lymph node—prostate cancer	0.000138	0.00333	CbGeAlD
Melatonin—CALM1—lymph node—prostate cancer	0.000138	0.00332	CbGeAlD
Melatonin—Almotriptan—CYP3A4—prostate cancer	0.000106	0.0975	CrCbGaD
Melatonin—CYP1A1—lymph node—prostate cancer	0.000106	0.00255	CbGeAlD
Melatonin—Asthenia—Estradiol—prostate cancer	3.69e-05	0.000368	CcSEcCtD
Melatonin—Angiopathy—Prednisone—prostate cancer	3.65e-05	0.000364	CcSEcCtD
Melatonin—Syncope—Docetaxel—prostate cancer	3.64e-05	0.000363	CcSEcCtD
Melatonin—Pruritus—Estradiol—prostate cancer	3.64e-05	0.000363	CcSEcCtD
Melatonin—Leukopenia—Docetaxel—prostate cancer	3.63e-05	0.000362	CcSEcCtD
Melatonin—Immune system disorder—Prednisone—prostate cancer	3.63e-05	0.000362	CcSEcCtD
Melatonin—Palpitations—Docetaxel—prostate cancer	3.59e-05	0.000358	CcSEcCtD
Melatonin—Paraesthesia—Etoposide—prostate cancer	3.58e-05	0.000357	CcSEcCtD
Melatonin—Weight increased—Epirubicin—prostate cancer	3.58e-05	0.000356	CcSEcCtD
Melatonin—Loss of consciousness—Docetaxel—prostate cancer	3.57e-05	0.000356	CcSEcCtD
Melatonin—Somnolence—Etoposide—prostate cancer	3.54e-05	0.000353	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—prostate cancer	3.54e-05	0.000353	CcSEcCtD
Melatonin—Vertigo—Capecitabine—prostate cancer	3.53e-05	0.000352	CcSEcCtD
Melatonin—Hypersensitivity—Mitoxantrone—prostate cancer	3.53e-05	0.000352	CcSEcCtD
Melatonin—Syncope—Capecitabine—prostate cancer	3.52e-05	0.000351	CcSEcCtD
Melatonin—Mental disorder—Prednisone—prostate cancer	3.52e-05	0.000351	CcSEcCtD
Melatonin—Leukopenia—Capecitabine—prostate cancer	3.52e-05	0.000351	CcSEcCtD
Melatonin—Hypertension—Docetaxel—prostate cancer	3.51e-05	0.000349	CcSEcCtD
Melatonin—Infestation NOS—Epirubicin—prostate cancer	3.5e-05	0.000349	CcSEcCtD
Melatonin—Infestation—Epirubicin—prostate cancer	3.5e-05	0.000349	CcSEcCtD
Melatonin—Malnutrition—Prednisone—prostate cancer	3.5e-05	0.000349	CcSEcCtD
Melatonin—Erythema—Prednisone—prostate cancer	3.5e-05	0.000349	CcSEcCtD
Melatonin—Palpitations—Capecitabine—prostate cancer	3.47e-05	0.000346	CcSEcCtD
Melatonin—Arthralgia—Docetaxel—prostate cancer	3.46e-05	0.000344	CcSEcCtD
Melatonin—Chest pain—Docetaxel—prostate cancer	3.46e-05	0.000344	CcSEcCtD
Melatonin—Loss of consciousness—Capecitabine—prostate cancer	3.45e-05	0.000344	CcSEcCtD
Melatonin—Gastrointestinal disorder—Etoposide—prostate cancer	3.44e-05	0.000343	CcSEcCtD
Melatonin—Asthenia—Mitoxantrone—prostate cancer	3.44e-05	0.000343	CcSEcCtD
Melatonin—Fatigue—Etoposide—prostate cancer	3.44e-05	0.000343	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	3.43e-05	0.000342	CcSEcCtD
Melatonin—Stomatitis—Epirubicin—prostate cancer	3.42e-05	0.00034	CcSEcCtD
Melatonin—Pain—Etoposide—prostate cancer	3.41e-05	0.00034	CcSEcCtD
Melatonin—Dizziness—Estradiol—prostate cancer	3.4e-05	0.000339	CcSEcCtD
Melatonin—Hypertension—Capecitabine—prostate cancer	3.39e-05	0.000338	CcSEcCtD
Melatonin—Dry mouth—Docetaxel—prostate cancer	3.38e-05	0.000337	CcSEcCtD
Melatonin—Chest pain—Capecitabine—prostate cancer	3.35e-05	0.000333	CcSEcCtD
Melatonin—Arthralgia—Capecitabine—prostate cancer	3.35e-05	0.000333	CcSEcCtD
Melatonin—Haematuria—Epirubicin—prostate cancer	3.34e-05	0.000333	CcSEcCtD
Melatonin—Anxiety—Capecitabine—prostate cancer	3.33e-05	0.000332	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	3.32e-05	0.000331	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—prostate cancer	3.31e-05	0.00033	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—prostate cancer	3.31e-05	0.00033	CcSEcCtD
Melatonin—Vision blurred—Prednisone—prostate cancer	3.3e-05	0.000329	CcSEcCtD
Melatonin—Infection—Docetaxel—prostate cancer	3.29e-05	0.000328	CcSEcCtD
Melatonin—Dry mouth—Capecitabine—prostate cancer	3.27e-05	0.000326	CcSEcCtD
Melatonin—Vomiting—Estradiol—prostate cancer	3.27e-05	0.000326	CcSEcCtD
Melatonin—Gastrointestinal pain—Etoposide—prostate cancer	3.26e-05	0.000325	CcSEcCtD
Melatonin—Shock—Docetaxel—prostate cancer	3.26e-05	0.000325	CcSEcCtD
Melatonin—Nervous system disorder—Docetaxel—prostate cancer	3.25e-05	0.000324	CcSEcCtD
Melatonin—Thrombocytopenia—Docetaxel—prostate cancer	3.24e-05	0.000323	CcSEcCtD
Melatonin—Rash—Estradiol—prostate cancer	3.24e-05	0.000323	CcSEcCtD
Melatonin—Infestation—Doxorubicin—prostate cancer	3.24e-05	0.000323	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—prostate cancer	3.24e-05	0.000323	CcSEcCtD
Melatonin—Dermatitis—Estradiol—prostate cancer	3.24e-05	0.000323	CcSEcCtD
Melatonin—Headache—Estradiol—prostate cancer	3.22e-05	0.000321	CcSEcCtD
Melatonin—Skin disorder—Docetaxel—prostate cancer	3.22e-05	0.000321	CcSEcCtD
Melatonin—Agitation—Prednisone—prostate cancer	3.22e-05	0.000321	CcSEcCtD
Melatonin—Angioedema—Prednisone—prostate cancer	3.2e-05	0.000319	CcSEcCtD
Melatonin—Infection—Capecitabine—prostate cancer	3.19e-05	0.000318	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—prostate cancer	3.16e-05	0.000315	CcSEcCtD
Melatonin—Shock—Capecitabine—prostate cancer	3.16e-05	0.000315	CcSEcCtD
Melatonin—Abdominal pain—Etoposide—prostate cancer	3.15e-05	0.000314	CcSEcCtD
Melatonin—Nervous system disorder—Capecitabine—prostate cancer	3.15e-05	0.000314	CcSEcCtD
Melatonin—Vertigo—Prednisone—prostate cancer	3.15e-05	0.000313	CcSEcCtD
Melatonin—Thrombocytopenia—Capecitabine—prostate cancer	3.14e-05	0.000313	CcSEcCtD
Melatonin—Syncope—Prednisone—prostate cancer	3.14e-05	0.000313	CcSEcCtD
Melatonin—Skin disorder—Capecitabine—prostate cancer	3.12e-05	0.000311	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—prostate cancer	3.11e-05	0.00031	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—prostate cancer	3.09e-05	0.000308	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—prostate cancer	3.09e-05	0.000308	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—prostate cancer	3.08e-05	0.000307	CcSEcCtD
Melatonin—Loss of consciousness—Prednisone—prostate cancer	3.08e-05	0.000307	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—prostate cancer	3.07e-05	0.000306	CcSEcCtD
Melatonin—Nausea—Estradiol—prostate cancer	3.06e-05	0.000305	CcSEcCtD
Melatonin—Vomiting—Mitoxantrone—prostate cancer	3.05e-05	0.000304	CcSEcCtD
Melatonin—Hypertension—Prednisone—prostate cancer	3.02e-05	0.000301	CcSEcCtD
Melatonin—Rash—Mitoxantrone—prostate cancer	3.02e-05	0.000301	CcSEcCtD
Melatonin—Dermatitis—Mitoxantrone—prostate cancer	3.02e-05	0.000301	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.02e-05	0.000301	CcSEcCtD
Melatonin—Headache—Mitoxantrone—prostate cancer	3e-05	0.000299	CcSEcCtD
Melatonin—Insomnia—Docetaxel—prostate cancer	3e-05	0.000299	CcSEcCtD
Melatonin—Arthralgia—Prednisone—prostate cancer	2.98e-05	0.000297	CcSEcCtD
Melatonin—Paraesthesia—Docetaxel—prostate cancer	2.98e-05	0.000297	CcSEcCtD
Melatonin—Anxiety—Prednisone—prostate cancer	2.97e-05	0.000296	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.96e-05	0.000295	CcSEcCtD
Melatonin—Somnolence—Docetaxel—prostate cancer	2.95e-05	0.000294	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—prostate cancer	2.94e-05	0.000293	CcSEcCtD
Melatonin—Hypersensitivity—Etoposide—prostate cancer	2.94e-05	0.000293	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.92e-05	0.000291	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—prostate cancer	2.92e-05	0.000291	CcSEcCtD
Melatonin—Dyspepsia—Docetaxel—prostate cancer	2.92e-05	0.000291	CcSEcCtD
Melatonin—Insomnia—Capecitabine—prostate cancer	2.9e-05	0.000289	CcSEcCtD
Melatonin—Paraesthesia—Capecitabine—prostate cancer	2.88e-05	0.000287	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—prostate cancer	2.87e-05	0.000286	CcSEcCtD
Melatonin—Gastrointestinal disorder—Docetaxel—prostate cancer	2.86e-05	0.000285	CcSEcCtD
Melatonin—Asthenia—Etoposide—prostate cancer	2.86e-05	0.000285	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—prostate cancer	2.86e-05	0.000285	CcSEcCtD
Melatonin—Fatigue—Docetaxel—prostate cancer	2.86e-05	0.000285	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—prostate cancer	2.85e-05	0.000284	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—prostate cancer	2.85e-05	0.000284	CcSEcCtD
Melatonin—Nausea—Mitoxantrone—prostate cancer	2.85e-05	0.000284	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—prostate cancer	2.84e-05	0.000283	CcSEcCtD
Melatonin—Infection—Prednisone—prostate cancer	2.84e-05	0.000283	CcSEcCtD
Melatonin—Pain—Docetaxel—prostate cancer	2.83e-05	0.000282	CcSEcCtD
Melatonin—Dyspepsia—Capecitabine—prostate cancer	2.82e-05	0.000281	CcSEcCtD
Melatonin—Pruritus—Etoposide—prostate cancer	2.82e-05	0.000281	CcSEcCtD
Melatonin—Shock—Prednisone—prostate cancer	2.81e-05	0.00028	CcSEcCtD
Melatonin—Nervous system disorder—Prednisone—prostate cancer	2.8e-05	0.000279	CcSEcCtD
Melatonin—Skin disorder—Prednisone—prostate cancer	2.78e-05	0.000277	CcSEcCtD
Melatonin—Gastrointestinal disorder—Capecitabine—prostate cancer	2.77e-05	0.000276	CcSEcCtD
Melatonin—Fatigue—Capecitabine—prostate cancer	2.77e-05	0.000276	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—prostate cancer	2.76e-05	0.000275	CcSEcCtD
Melatonin—Pain—Capecitabine—prostate cancer	2.74e-05	0.000273	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—prostate cancer	2.74e-05	0.000273	CcSEcCtD
Melatonin—Erythema—Epirubicin—prostate cancer	2.74e-05	0.000273	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—prostate cancer	2.72e-05	0.000271	CcSEcCtD
Melatonin—Gastrointestinal pain—Docetaxel—prostate cancer	2.71e-05	0.00027	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—prostate cancer	2.7e-05	0.000269	CcSEcCtD
Melatonin—Flatulence—Epirubicin—prostate cancer	2.7e-05	0.000269	CcSEcCtD
Melatonin—Tension—Epirubicin—prostate cancer	2.69e-05	0.000268	CcSEcCtD
Melatonin—Nervousness—Epirubicin—prostate cancer	2.66e-05	0.000265	CcSEcCtD
Melatonin—Back pain—Epirubicin—prostate cancer	2.65e-05	0.000264	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—prostate cancer	2.64e-05	0.000263	CcSEcCtD
Melatonin—Dizziness—Etoposide—prostate cancer	2.64e-05	0.000263	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—prostate cancer	2.63e-05	0.000262	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—prostate cancer	2.63e-05	0.000262	CcSEcCtD
Melatonin—Gastrointestinal pain—Capecitabine—prostate cancer	2.62e-05	0.000261	CcSEcCtD
Melatonin—Abdominal pain—Docetaxel—prostate cancer	2.62e-05	0.000261	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Prednisone—prostate cancer	2.6e-05	0.000259	CcSEcCtD
Melatonin—Insomnia—Prednisone—prostate cancer	2.58e-05	0.000258	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—prostate cancer	2.58e-05	0.000257	CcSEcCtD
Melatonin—Paraesthesia—Prednisone—prostate cancer	2.57e-05	0.000256	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—prostate cancer	2.55e-05	0.000254	CcSEcCtD
Melatonin—Abdominal pain—Capecitabine—prostate cancer	2.54e-05	0.000253	CcSEcCtD
Melatonin—Vomiting—Etoposide—prostate cancer	2.53e-05	0.000253	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—prostate cancer	2.53e-05	0.000253	CcSEcCtD
Melatonin—Erythema—Doxorubicin—prostate cancer	2.53e-05	0.000253	CcSEcCtD
Melatonin—Agitation—Epirubicin—prostate cancer	2.52e-05	0.000251	CcSEcCtD
Melatonin—Dyspepsia—Prednisone—prostate cancer	2.52e-05	0.000251	CcSEcCtD
Melatonin—Rash—Etoposide—prostate cancer	2.51e-05	0.000251	CcSEcCtD
Melatonin—Dermatitis—Etoposide—prostate cancer	2.51e-05	0.00025	CcSEcCtD
Melatonin—Headache—Etoposide—prostate cancer	2.5e-05	0.000249	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—prostate cancer	2.5e-05	0.000249	CcSEcCtD
Melatonin—Tension—Doxorubicin—prostate cancer	2.49e-05	0.000248	CcSEcCtD
Melatonin—Fatigue—Prednisone—prostate cancer	2.46e-05	0.000246	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—prostate cancer	2.46e-05	0.000245	CcSEcCtD
Melatonin—Vertigo—Epirubicin—prostate cancer	2.46e-05	0.000245	CcSEcCtD
Melatonin—Syncope—Epirubicin—prostate cancer	2.46e-05	0.000245	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—prostate cancer	2.45e-05	0.000244	CcSEcCtD
Melatonin—Back pain—Doxorubicin—prostate cancer	2.45e-05	0.000244	CcSEcCtD
Melatonin—Hypersensitivity—Docetaxel—prostate cancer	2.44e-05	0.000243	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—prostate cancer	2.44e-05	0.000243	CcSEcCtD
Melatonin—Palpitations—Epirubicin—prostate cancer	2.42e-05	0.000241	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—prostate cancer	2.41e-05	0.00024	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—prostate cancer	2.39e-05	0.000238	CcSEcCtD
Melatonin—Asthenia—Docetaxel—prostate cancer	2.38e-05	0.000237	CcSEcCtD
Melatonin—Nausea—Etoposide—prostate cancer	2.37e-05	0.000236	CcSEcCtD
Melatonin—Hypertension—Epirubicin—prostate cancer	2.36e-05	0.000236	CcSEcCtD
Melatonin—Hypersensitivity—Capecitabine—prostate cancer	2.36e-05	0.000236	CcSEcCtD
Melatonin—Pruritus—Docetaxel—prostate cancer	2.34e-05	0.000234	CcSEcCtD
Melatonin—Gastrointestinal pain—Prednisone—prostate cancer	2.34e-05	0.000233	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—prostate cancer	2.33e-05	0.000232	CcSEcCtD
Melatonin—Chest pain—Epirubicin—prostate cancer	2.33e-05	0.000232	CcSEcCtD
Melatonin—Agitation—Doxorubicin—prostate cancer	2.33e-05	0.000232	CcSEcCtD
Melatonin—Anxiety—Epirubicin—prostate cancer	2.32e-05	0.000232	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.32e-05	0.000231	CcSEcCtD
Melatonin—Asthenia—Capecitabine—prostate cancer	2.3e-05	0.000229	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—prostate cancer	2.28e-05	0.000227	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—prostate cancer	2.28e-05	0.000227	CcSEcCtD
Melatonin—Syncope—Doxorubicin—prostate cancer	2.27e-05	0.000226	CcSEcCtD
Melatonin—Pruritus—Capecitabine—prostate cancer	2.27e-05	0.000226	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—prostate cancer	2.27e-05	0.000226	CcSEcCtD
Melatonin—Abdominal pain—Prednisone—prostate cancer	2.26e-05	0.000225	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—prostate cancer	2.24e-05	0.000223	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—prostate cancer	2.23e-05	0.000222	CcSEcCtD
Melatonin—Infection—Epirubicin—prostate cancer	2.22e-05	0.000221	CcSEcCtD
Melatonin—Shock—Epirubicin—prostate cancer	2.2e-05	0.000219	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—prostate cancer	2.19e-05	0.000218	CcSEcCtD
Melatonin—Dizziness—Docetaxel—prostate cancer	2.19e-05	0.000218	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—prostate cancer	2.19e-05	0.000218	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—prostate cancer	2.19e-05	0.000218	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—prostate cancer	2.17e-05	0.000216	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—prostate cancer	2.16e-05	0.000215	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—prostate cancer	2.16e-05	0.000215	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—prostate cancer	2.15e-05	0.000214	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.14e-05	0.000213	CcSEcCtD
Melatonin—Dizziness—Capecitabine—prostate cancer	2.12e-05	0.000211	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—prostate cancer	2.11e-05	0.00021	CcSEcCtD
Melatonin—Vomiting—Docetaxel—prostate cancer	2.11e-05	0.00021	CcSEcCtD
Melatonin—Hypersensitivity—Prednisone—prostate cancer	2.11e-05	0.00021	CcSEcCtD
Melatonin—Rash—Docetaxel—prostate cancer	2.09e-05	0.000208	CcSEcCtD
Melatonin—Dermatitis—Docetaxel—prostate cancer	2.09e-05	0.000208	CcSEcCtD
Melatonin—Headache—Docetaxel—prostate cancer	2.08e-05	0.000207	CcSEcCtD
Melatonin—Infection—Doxorubicin—prostate cancer	2.05e-05	0.000205	CcSEcCtD
Melatonin—Asthenia—Prednisone—prostate cancer	2.05e-05	0.000204	CcSEcCtD
Melatonin—Vomiting—Capecitabine—prostate cancer	2.04e-05	0.000203	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.04e-05	0.000203	CcSEcCtD
Melatonin—Shock—Doxorubicin—prostate cancer	2.03e-05	0.000203	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—prostate cancer	2.03e-05	0.000202	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—prostate cancer	2.02e-05	0.000202	CcSEcCtD
Melatonin—Rash—Capecitabine—prostate cancer	2.02e-05	0.000202	CcSEcCtD
Melatonin—Pruritus—Prednisone—prostate cancer	2.02e-05	0.000201	CcSEcCtD
Melatonin—Insomnia—Epirubicin—prostate cancer	2.02e-05	0.000201	CcSEcCtD
Melatonin—Dermatitis—Capecitabine—prostate cancer	2.02e-05	0.000201	CcSEcCtD
Melatonin—Headache—Capecitabine—prostate cancer	2.01e-05	0.0002	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—prostate cancer	2.01e-05	0.0002	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—prostate cancer	2.01e-05	0.0002	CcSEcCtD
Melatonin—Somnolence—Epirubicin—prostate cancer	1.99e-05	0.000198	CcSEcCtD
Melatonin—Nausea—Docetaxel—prostate cancer	1.97e-05	0.000196	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—prostate cancer	1.97e-05	0.000196	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—prostate cancer	1.93e-05	0.000192	CcSEcCtD
Melatonin—Fatigue—Epirubicin—prostate cancer	1.93e-05	0.000192	CcSEcCtD
Melatonin—Pain—Epirubicin—prostate cancer	1.91e-05	0.00019	CcSEcCtD
Melatonin—Nausea—Capecitabine—prostate cancer	1.91e-05	0.00019	CcSEcCtD
Melatonin—Dizziness—Prednisone—prostate cancer	1.89e-05	0.000188	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.88e-05	0.000188	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—prostate cancer	1.87e-05	0.000186	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—prostate cancer	1.86e-05	0.000185	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—prostate cancer	1.84e-05	0.000183	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—prostate cancer	1.83e-05	0.000182	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—prostate cancer	1.82e-05	0.000181	CcSEcCtD
Melatonin—Vomiting—Prednisone—prostate cancer	1.82e-05	0.000181	CcSEcCtD
Melatonin—Rash—Prednisone—prostate cancer	1.8e-05	0.00018	CcSEcCtD
Melatonin—Dermatitis—Prednisone—prostate cancer	1.8e-05	0.000179	CcSEcCtD
Melatonin—Headache—Prednisone—prostate cancer	1.79e-05	0.000178	CcSEcCtD
Melatonin—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.79e-05	0.000178	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—prostate cancer	1.78e-05	0.000178	CcSEcCtD
Melatonin—Pain—Doxorubicin—prostate cancer	1.77e-05	0.000176	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—prostate cancer	1.77e-05	0.000176	CcSEcCtD
Melatonin—Nausea—Prednisone—prostate cancer	1.7e-05	0.000169	CcSEcCtD
Melatonin—Gastrointestinal pain—Doxorubicin—prostate cancer	1.69e-05	0.000169	CcSEcCtD
Melatonin—Hypersensitivity—Epirubicin—prostate cancer	1.65e-05	0.000164	CcSEcCtD
Melatonin—Abdominal pain—Doxorubicin—prostate cancer	1.63e-05	0.000163	CcSEcCtD
Melatonin—Asthenia—Epirubicin—prostate cancer	1.6e-05	0.00016	CcSEcCtD
Melatonin—Pruritus—Epirubicin—prostate cancer	1.58e-05	0.000158	CcSEcCtD
Melatonin—Hypersensitivity—Doxorubicin—prostate cancer	1.52e-05	0.000152	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—prostate cancer	1.48e-05	0.000148	CcSEcCtD
Melatonin—Dizziness—Epirubicin—prostate cancer	1.48e-05	0.000147	CcSEcCtD
Melatonin—Pruritus—Doxorubicin—prostate cancer	1.46e-05	0.000146	CcSEcCtD
Melatonin—Vomiting—Epirubicin—prostate cancer	1.42e-05	0.000142	CcSEcCtD
Melatonin—Rash—Epirubicin—prostate cancer	1.41e-05	0.00014	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—prostate cancer	1.41e-05	0.00014	CcSEcCtD
Melatonin—Headache—Epirubicin—prostate cancer	1.4e-05	0.00014	CcSEcCtD
Melatonin—Dizziness—Doxorubicin—prostate cancer	1.37e-05	0.000136	CcSEcCtD
Melatonin—Nausea—Epirubicin—prostate cancer	1.33e-05	0.000132	CcSEcCtD
Melatonin—Vomiting—Doxorubicin—prostate cancer	1.31e-05	0.000131	CcSEcCtD
Melatonin—Rash—Doxorubicin—prostate cancer	1.3e-05	0.00013	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—prostate cancer	1.3e-05	0.00013	CcSEcCtD
Melatonin—Headache—Doxorubicin—prostate cancer	1.3e-05	0.000129	CcSEcCtD
Melatonin—Nausea—Doxorubicin—prostate cancer	1.23e-05	0.000122	CcSEcCtD
Melatonin—CYP2C19—Metabolism—PIK3CG—prostate cancer	5.1e-07	4.86e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—GSK3B—prostate cancer	5.1e-07	4.85e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—GSK3B—prostate cancer	5.1e-07	4.85e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CREBBP—prostate cancer	5.09e-07	4.85e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CYP1A1—prostate cancer	5.07e-07	4.83e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—SRC—prostate cancer	5.04e-07	4.8e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—SRC—prostate cancer	5.04e-07	4.8e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—CDKN1A—prostate cancer	5.03e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—CDKN1A—prostate cancer	5.03e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CB—prostate cancer	5.03e-07	4.79e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ERCC2—prostate cancer	5.03e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—STAT3—prostate cancer	5.03e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—INS—prostate cancer	5.03e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—INS—prostate cancer	5.03e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IGF1—prostate cancer	5.03e-07	4.79e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—PTEN—prostate cancer	5.02e-07	4.78e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—PTEN—prostate cancer	5.02e-07	4.78e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—prostate cancer	5e-07	4.76e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—prostate cancer	4.99e-07	4.75e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EP300—prostate cancer	4.97e-07	4.73e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—EP300—prostate cancer	4.95e-07	4.72e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CREBBP—prostate cancer	4.92e-07	4.69e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CREBBP—prostate cancer	4.92e-07	4.69e-06	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—prostate cancer	4.91e-07	4.67e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.88e-07	4.64e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CB—prostate cancer	4.87e-07	4.64e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CB—prostate cancer	4.87e-07	4.64e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—prostate cancer	4.86e-07	4.63e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—prostate cancer	4.86e-07	4.63e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF1—prostate cancer	4.86e-07	4.63e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF1—prostate cancer	4.86e-07	4.63e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAP2K1—prostate cancer	4.86e-07	4.63e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—prostate cancer	4.84e-07	4.61e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—prostate cancer	4.84e-07	4.61e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SRC—prostate cancer	4.83e-07	4.6e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CD—prostate cancer	4.83e-07	4.6e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—INS—prostate cancer	4.83e-07	4.6e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—prostate cancer	4.82e-07	4.59e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—prostate cancer	4.82e-07	4.59e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—SRC—prostate cancer	4.81e-07	4.59e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—EP300—prostate cancer	4.79e-07	4.56e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—EP300—prostate cancer	4.79e-07	4.56e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CB—prostate cancer	4.77e-07	4.55e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SERPINE1—prostate cancer	4.77e-07	4.55e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—prostate cancer	4.73e-07	4.51e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—MTHFR—prostate cancer	4.73e-07	4.5e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CREBBP—prostate cancer	4.73e-07	4.5e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—prostate cancer	4.73e-07	4.5e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—prostate cancer	4.73e-07	4.5e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—prostate cancer	4.7e-07	4.48e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAP2K1—prostate cancer	4.7e-07	4.48e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAP2K1—prostate cancer	4.7e-07	4.48e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CD—prostate cancer	4.67e-07	4.45e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CD—prostate cancer	4.67e-07	4.45e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—SRC—prostate cancer	4.66e-07	4.44e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—SRC—prostate cancer	4.66e-07	4.44e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—prostate cancer	4.66e-07	4.44e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CG—prostate cancer	4.65e-07	4.43e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—prostate cancer	4.64e-07	4.42e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARA—prostate cancer	4.64e-07	4.42e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FGF2—prostate cancer	4.62e-07	4.4e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SERPINE1—prostate cancer	4.62e-07	4.4e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SERPINE1—prostate cancer	4.62e-07	4.4e-06	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—prostate cancer	4.62e-07	4.4e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—prostate cancer	4.57e-07	4.35e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—prostate cancer	4.57e-07	4.35e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—prostate cancer	4.57e-07	4.35e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NOS3—prostate cancer	4.56e-07	4.34e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—prostate cancer	4.49e-07	4.28e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—prostate cancer	4.49e-07	4.28e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CD—prostate cancer	4.48e-07	4.27e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FGF2—prostate cancer	4.47e-07	4.26e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FGF2—prostate cancer	4.47e-07	4.26e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—JAK2—prostate cancer	4.43e-07	4.22e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—prostate cancer	4.42e-07	4.21e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—prostate cancer	4.42e-07	4.21e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NOS3—prostate cancer	4.41e-07	4.2e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NOS3—prostate cancer	4.41e-07	4.2e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—INS—prostate cancer	4.4e-07	4.19e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CAV1—prostate cancer	4.36e-07	4.15e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—prostate cancer	4.35e-07	4.14e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—prostate cancer	4.34e-07	4.14e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—prostate cancer	4.33e-07	4.12e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MDM2—prostate cancer	4.32e-07	4.12e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—prostate cancer	4.32e-07	4.11e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TGFB1—prostate cancer	4.32e-07	4.11e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—prostate cancer	4.31e-07	4.11e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CREBBP—prostate cancer	4.31e-07	4.11e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFB1—prostate cancer	4.3e-07	4.1e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—JAK2—prostate cancer	4.28e-07	4.08e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—JAK2—prostate cancer	4.28e-07	4.08e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB2—prostate cancer	4.26e-07	4.06e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—prostate cancer	4.23e-07	4.03e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—NOS3—prostate cancer	4.23e-07	4.03e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—prostate cancer	4.22e-07	4.02e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CB—prostate cancer	4.21e-07	4.01e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—prostate cancer	4.21e-07	4.01e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—prostate cancer	4.21e-07	4.01e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—prostate cancer	4.2e-07	4e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—prostate cancer	4.2e-07	4e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MDM2—prostate cancer	4.18e-07	3.98e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MDM2—prostate cancer	4.18e-07	3.98e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—prostate cancer	4.18e-07	3.98e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—prostate cancer	4.18e-07	3.98e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—prostate cancer	4.17e-07	3.98e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—prostate cancer	4.17e-07	3.98e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.17e-07	3.97e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFB1—prostate cancer	4.16e-07	3.97e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFB1—prostate cancer	4.16e-07	3.97e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—EP300—prostate cancer	4.15e-07	3.95e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—prostate cancer	4.13e-07	3.93e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB2—prostate cancer	4.12e-07	3.93e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB2—prostate cancer	4.12e-07	3.93e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CD—prostate cancer	4.09e-07	3.89e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—prostate cancer	4.08e-07	3.89e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—prostate cancer	4.08e-07	3.89e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CB—prostate cancer	4.07e-07	3.88e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CB—prostate cancer	4.07e-07	3.88e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL8—prostate cancer	4.04e-07	3.85e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—EP300—prostate cancer	4.01e-07	3.82e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—EP300—prostate cancer	4.01e-07	3.82e-06	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—prostate cancer	4.01e-07	3.82e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—prostate cancer	4e-07	3.81e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—prostate cancer	3.99e-07	3.8e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CG—prostate cancer	3.97e-07	3.78e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—prostate cancer	3.97e-07	3.78e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1B—prostate cancer	3.95e-07	3.76e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—EP300—prostate cancer	3.93e-07	3.75e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL8—prostate cancer	3.91e-07	3.73e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL8—prostate cancer	3.91e-07	3.73e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CB—prostate cancer	3.91e-07	3.72e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—prostate cancer	3.87e-07	3.69e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—prostate cancer	3.87e-07	3.69e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—prostate cancer	3.86e-07	3.68e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—prostate cancer	3.86e-07	3.68e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—NOS3—prostate cancer	3.86e-07	3.68e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—prostate cancer	3.86e-07	3.67e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—prostate cancer	3.86e-07	3.67e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—prostate cancer	3.84e-07	3.66e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—prostate cancer	3.84e-07	3.65e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—prostate cancer	3.84e-07	3.65e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1B—prostate cancer	3.82e-07	3.64e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1B—prostate cancer	3.82e-07	3.64e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—prostate cancer	3.77e-07	3.59e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—INS—prostate cancer	3.76e-07	3.58e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—prostate cancer	3.74e-07	3.57e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—prostate cancer	3.74e-07	3.57e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—prostate cancer	3.74e-07	3.56e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—prostate cancer	3.74e-07	3.56e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—prostate cancer	3.73e-07	3.55e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—prostate cancer	3.72e-07	3.54e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—prostate cancer	3.72e-07	3.54e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CREBBP—prostate cancer	3.68e-07	3.51e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—prostate cancer	3.67e-07	3.5e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—prostate cancer	3.66e-07	3.49e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—prostate cancer	3.66e-07	3.48e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1A—prostate cancer	3.64e-07	3.47e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—prostate cancer	3.64e-07	3.47e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—prostate cancer	3.64e-07	3.47e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—prostate cancer	3.64e-07	3.46e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—prostate cancer	3.61e-07	3.44e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—prostate cancer	3.61e-07	3.44e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CB—prostate cancer	3.56e-07	3.39e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—prostate cancer	3.55e-07	3.38e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—prostate cancer	3.55e-07	3.38e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—prostate cancer	3.54e-07	3.37e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—prostate cancer	3.54e-07	3.37e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—prostate cancer	3.54e-07	3.37e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—prostate cancer	3.54e-07	3.37e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—prostate cancer	3.53e-07	3.36e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1A—prostate cancer	3.52e-07	3.36e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1A—prostate cancer	3.52e-07	3.36e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—prostate cancer	3.52e-07	3.35e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—prostate cancer	3.52e-07	3.35e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—prostate cancer	3.51e-07	3.35e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CD—prostate cancer	3.49e-07	3.33e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EP300—prostate cancer	3.47e-07	3.3e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—prostate cancer	3.43e-07	3.27e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—prostate cancer	3.43e-07	3.27e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—prostate cancer	3.4e-07	3.24e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—prostate cancer	3.4e-07	3.24e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—prostate cancer	3.38e-07	3.22e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SRC—prostate cancer	3.37e-07	3.21e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EP300—prostate cancer	3.35e-07	3.19e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EP300—prostate cancer	3.35e-07	3.19e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—NOS3—prostate cancer	3.3e-07	3.14e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—prostate cancer	3.28e-07	3.13e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SRC—prostate cancer	3.26e-07	3.11e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SRC—prostate cancer	3.26e-07	3.11e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—prostate cancer	3.25e-07	3.1e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—prostate cancer	3.25e-07	3.1e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—prostate cancer	3.24e-07	3.09e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—prostate cancer	3.24e-07	3.09e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—EP300—prostate cancer	3.22e-07	3.07e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—prostate cancer	3.18e-07	3.03e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—prostate cancer	3.18e-07	3.03e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—prostate cancer	3.15e-07	3e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—prostate cancer	3.15e-07	3e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—prostate cancer	3.14e-07	2.99e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—prostate cancer	3.14e-07	2.99e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—prostate cancer	3.13e-07	2.99e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—prostate cancer	3.13e-07	2.99e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—prostate cancer	3.08e-07	2.93e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—prostate cancer	3.07e-07	2.92e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CB—prostate cancer	3.04e-07	2.9e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—prostate cancer	3.02e-07	2.88e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—prostate cancer	3.02e-07	2.87e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFB1—prostate cancer	3.01e-07	2.87e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—prostate cancer	3e-07	2.86e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—prostate cancer	2.99e-07	2.85e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—prostate cancer	2.97e-07	2.83e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—prostate cancer	2.97e-07	2.83e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—prostate cancer	2.95e-07	2.81e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—EP300—prostate cancer	2.94e-07	2.8e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—prostate cancer	2.92e-07	2.78e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—prostate cancer	2.92e-07	2.78e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFB1—prostate cancer	2.92e-07	2.78e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFB1—prostate cancer	2.92e-07	2.78e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—prostate cancer	2.91e-07	2.77e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—prostate cancer	2.89e-07	2.76e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—prostate cancer	2.89e-07	2.76e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—prostate cancer	2.86e-07	2.72e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—prostate cancer	2.86e-07	2.72e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—prostate cancer	2.79e-07	2.66e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—prostate cancer	2.7e-07	2.57e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—prostate cancer	2.7e-07	2.57e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—prostate cancer	2.63e-07	2.51e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—prostate cancer	2.56e-07	2.44e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—EP300—prostate cancer	2.51e-07	2.39e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—prostate cancer	2.51e-07	2.39e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—prostate cancer	2.48e-07	2.36e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—prostate cancer	2.48e-07	2.36e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—prostate cancer	2.48e-07	2.36e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—prostate cancer	2.42e-07	2.31e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—prostate cancer	2.42e-07	2.31e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—prostate cancer	2.4e-07	2.29e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—prostate cancer	2.4e-07	2.29e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—prostate cancer	2.38e-07	2.27e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—prostate cancer	2.38e-07	2.26e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—prostate cancer	2.27e-07	2.16e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—prostate cancer	2.2e-07	2.09e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—prostate cancer	2.2e-07	2.09e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.17e-07	2.07e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—prostate cancer	2.1e-07	2e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—prostate cancer	2.03e-07	1.93e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—prostate cancer	2.03e-07	1.93e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—prostate cancer	1.95e-07	1.85e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.86e-07	1.77e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—prostate cancer	1.77e-07	1.69e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—prostate cancer	1.52e-07	1.44e-06	CbGpPWpGaD
